0001140361-18-014256.txt : 20180320
0001140361-18-014256.hdr.sgml : 20180320
20180320141631
ACCESSION NUMBER: 0001140361-18-014256
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180320
DATE AS OF CHANGE: 20180320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES
CENTRAL INDEX KEY: 0001221590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 18701517
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2018-03-15
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001221590
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
1
1
0
0
Chief Executive Officer
Common Stock
2018-03-15
2018-03-15
4
M
0
15000
38.59
A
279674
D
Common Stock
2018-03-15
2018-03-15
4
S
0
15000
84.7267
D
264674
D
Common Stock
2018-03-15
2018-03-15
4
F
0
14908
83.57
D
249766
D
Common Stock
2018-03-15
2018-03-15
4
A
0
46340
0
A
296106
D
Common Stock
182201
I
Shares held by Jean-Jacques Bienaime Family Trust
Stock Option (Right to buy Common Stock)
38.59
2018-03-15
2018-03-15
4
M
0
15000
38.59
A
2008-11-22
2018-05-21
Common Stock
15000
157500
D
Stock Option (Right to buy Common Stock)
83.57
2018-03-15
2018-03-15
4
A
0
148190
0
A
2019-03-15
2028-03-14
Common Stock
148190
148190
D
This transaction, originally due to be reported on Monday, March 19, 2018, is being reported late due to an administrative oversight.
Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.
The price in column 4 is the weighted average price. The price actually received ranged from $84.26 to $85.91. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
Restricted stock units granted on March 15, 2018. Price not applicable.
Option grant vests 12/48th on March 15, 2019 and 1/48th on the 15th day of each month thereafter.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2018-03-20